XML 21 R9.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income (loss) $ 25,496 $ 29,202
Adjustments to reconcile net income to net cash provided by operating activities:    
Provision for losses on accounts receivable 0 (46)
Reversal of gain on sales to equity method investee (2) (28)
Depreciation and amortization 67,869 64,460
Deferred income tax expense 5,253 5,426
Income tax expense arising from restricted share vesting and stock options exercised (322) (658)
Stock-based compensation expense 2,996 2,700
Income from equity method investment (11,622) (11,763)
Return on investment from equity method investee 5,145 3,675
(Gain) loss on disposition of property and equipment (3,039) 1,748
Changes in operating assets and liabilities:    
Receivables and advances (11,453) 7,704
Prepaid expenses and other assets (1,659) (4,080)
Inventory and supplies (497) (1,261)
Insurance and claims accrual 3,705 8,242
Accounts payable and accrued expenses 6,231 (4,360)
Net cash flows provided by operating activities 88,101 100,961
Cash flows from investing activities:    
Acquisition, net of cash acquired 0 (4,556)
Other investments (788) (488)
Purchase of property and equipment (119,044) (131,494)
Proceeds from disposition of property and equipment 30,651 32,332
Net cash flows used in investing activities (89,181) (104,206)
Cash flows from financing activities:    
Cash dividend (5,408) (4,341)
Proceeds from notes payable 86,174 104,785
Repayments of notes payable (69,835) (45,949)
Repayments of finance lease obligations (555) (553)
Proceeds under revolving credit facility 75,214 57,247
Repayments under revolving credit facility (75,214) (68,826)
Payment of contingent consideration liability (4,951) (7,023)
Proceeds from exercise of stock options 399 1,147
Payment of minimum tax withholdings on stock compensation (1,099) (339)
Common stock repurchased (36,578) 0
Net cash flows (used in) provided by financing activities (31,853) 36,148
Net change in cash and cash equivalents (32,933) 32,903
Cash and cash equivalents at beginning of period 35,619 2,294
Cash and cash equivalents at end of period $ 2,686 $ 35,197